Drug Shortage Report for LOSARTAN HCT
Report ID | 74303 |
Drug Identification Number | 02388979 |
Brand name | LOSARTAN HCT |
Common or Proper name | LOSARTAN HCT |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | DORMANT |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2019-02-11 |
Actual start date | 2019-02-18 |
Estimated end date | 2019-03-08 |
Actual end date | 2019-03-08 |
Shortage status | Resolved |
Updated date | 2019-03-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-03-11 | French | Compare |
v9 | 2019-03-11 | English | Compare |
v8 | 2019-03-04 | French | Compare |
v7 | 2019-03-04 | English | Compare |
v6 | 2019-02-19 | English | Compare |
v5 | 2019-02-18 | French | Compare |
v4 | 2019-02-18 | English | Compare |
v3 | 2019-02-12 | English | Compare |
v2 | 2019-02-01 | French | Compare |
v1 | 2019-02-01 | English | Compare |
Showing 1 to 10 of 10